Robert Allen

Technik-/Wissenschafts-/F&E-Leiter bei INVIVYD, INC.

Vermögen: - $ am 31.05.2024

55 Jahre

Consumer Services

Health Technology

Aktive Positionen von Robert Allen

Unternehmen	Position	Beginn	Ende
INVIVYD, INC.	Technik-/Wissenschafts-/F&E-Leiter	12.04.2023	-

Unternehmen	Position	Beginn	Ende
SmartPharm Therapeutics, Inc. SmartPharm Therapeutics, Inc. BiotechnologyHealth Technology SmartPharm Therapeutics, Inc. engages in the development of next-generation, non-viral gene therapies for the treatment of serious or rare diseases. Its pipeline include Gene MAbs for SARS-Cov-2, enzyme replacement therapy, and cell and tissue restoration. The company was founded by José Trevejo in 2017 and is headquartered in Cambridge, MA.	Technik-/Wissenschafts-/F&E-Leiter	01.01.2020	01.01.2023
Oregon Translational Research & Development Institute	Technik-/Wissenschafts-/F&E-Leiter	-	-
SORRENTO THERAPEUTICS, INC.	Technik-/Wissenschafts-/F&E-Leiter	-	-

The Trustees of Columbia University in The City of New York	Doctorate Degree
Georgia Institute of Technology	Graduate Degree
Rhodes College	Undergraduate Degree

International

Vereinigte Staaten

Operativ

Sektoral

Consumer Services	4
Health Technology	4

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	2
SORRENTO THERAPEUTICS, INC.	Health Technology
INVIVYD, INC.	Health Technology

Private Unternehmen	2
Oregon Translational Research & Development Institute
SmartPharm Therapeutics, Inc. SmartPharm Therapeutics, Inc. BiotechnologyHealth Technology SmartPharm Therapeutics, Inc. engages in the development of next-generation, non-viral gene therapies for the treatment of serious or rare diseases. Its pipeline include Gene MAbs for SARS-Cov-2, enzyme replacement therapy, and cell and tissue restoration. The company was founded by José Trevejo in 2017 and is headquartered in Cambridge, MA.	Health Technology

Private Unternehmen

Oregon Translational Research & Development Institute

Health Technology